702
Views
33
CrossRef citations to date
0
Altmetric
Review Article

Organ-specific toxicity of magnetic iron oxide-based nanoparticles

, , ORCID Icon, &
Pages 167-204 | Received 21 Sep 2020, Accepted 22 Oct 2020, Published online: 20 Nov 2020

References

  • Ahmad, F., X. Liu, Y. Zhou, H. Yao, F. Zhao, Z. Ling, and C. Xu. 2016. “Assessment of Thyroid Endocrine System Impairment and Oxidative Stress Mediated by Cobalt Ferrite (CoFe2 O4) Nanoparticles in Zebrafish Larvae.” Environmental Toxicology 31 (12): 2068–2080. doi:10.1002/tox.22206.
  • Akilo, O. D., Y. E. Choonara, A. M. Strydom, L. C. Du Toit, P. Kumar, G. Modi, and V. Pillay. 2016. “An in Vitro Evaluation of a Carmustine-Loaded Nano-co-Plex for Potential Magnetic-Targeted Intranasal Delivery to the Brain.” International Journal of Pharmaceutics 500 (1–2): 196–209. doi:10.1016/j.ijpharm.2016.01.043.
  • Akter, M., M. T. Sikder, M. M. Rahman, A. K. M. Ullah, F. B. Hossain, S. Banik, T. Hosokawa, et al. 2018. “A Systematic Review on Silver Nanoparticles-Induced Cytotoxicity: Physicochemical Properties and Perspectives.” Journal of Advanced Research 9: 1–16. doi:10.1016/j.jare.2017.10.008.
  • Alabi, O. A., A. H. Silva, L. R. P. Purnhagen, G. R. R. Souza, M. L. de, Júnior, F. B. Filippin-Monteiro, M. Dalmina, et al. 2019. “Genetic, Reproductive and Oxidative Damage in Mice Triggered by Co-exposure of Nanoparticles: From a Hypothetical Scenario to a Real Concern.” Science of the Total Environment 660: 1264–1273. doi:10.1016/j.scitotenv.2019.01.036.
  • Alarifi, S., D. Ali, and S. Alkahtani. 2015. “Nanoalumina Induces Apoptosis by Impairing Antioxidant Enzyme Systems in Human Hepatocarcinoma Cells.” International Journal of Nanomedicine 10: 3751–3760. doi:10.2147/IJN.S82050.
  • Almeida, S. O., and M. Budoff. 2019. “Effect of Statins on Atherosclerotic Plaque.” Trends in Cardiovascular Medicine 29 (8): 451–455. doi:10.1016/j.tcm.2019.01.001.
  • Amin, R. M., A. Abdelmonem, T. Verwanger, E. Elsherbini, and B. Krammer. 2014. “Cytotoxicity of Magnetic Nanoparticles on Normal and Malignant Human Skin Cells.” Nano LIFE 04 (01): 1440002. doi:10.1142/S1793984414400029.
  • Anderson, Lisa J., Mark A. Westwood, Sally Holden, Bernard Davis, Emma Prescott, Beatrix Wonke, John B. Porter, et al. 2004. “Myocardial Iron Clearance during Reversal of Siderotic Cardiomyopathy with Intravenous Desferrioxamine: A Prospective Study Using T2 Cardiovascular Magnetic Resonance.” British Journal of Haematology 127 (3): 348–355. doi:10.1111/j.1365-2141.2004.05202.x.
  • Ansari, S. A. M. K., E. Ficiarà, F. A. Ruffinatti, I. Stura, M. Argenziano, O. Abollino, R. Cavalli, et al. 2019. “Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Functionalization for Biomedical Applications in the Central Nervous System.” Materials (Basel) 12 (3): 465. doi:10.3390/ma12030465.
  • Arami, Hamed, Amit P. Khandhar, Asahi Tomitaka, Elaine Yu, Patrick W. Goodwill, Steven M. Conolly, and Kannan M. Krishnan. 2015a. “In Vivo Multimodal Magnetic Particle Imaging (MPI) with Tailored Magneto/Optical Contrast Agents.” Biomaterials 52: 251–261. doi:10.1016/j.biomaterials.2015.02.040.
  • Arami, H., A. P. Khandhar, D. Liggitt, and K. M. Krishnan. 2015b. “In Vivo Delivery, Pharmacokinetics, Biodistribution and Toxicity of Iron Oxide Nanoparticles.” Chemical Society Reviews 44 (23): 8576–8607. doi:10.1039/C5CS00541H.
  • Arias, L. S., J. P. Pessan, A. P. M. Vieira, T. M. T. Lima, A. C. B. Delbem, and D. R. Monteiro. 2018. “Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.” Antibiotics (Basel) 7 (2): 46. doi:10.3390/antibiotics7020046.
  • Askri, D., S. Ouni, S. Galai, J. Arnaud, B. Chovelon, S. G. Lehmann, N. Sturm, et al. 2018a. “Intranasal Instillation of Iron Oxide Nanoparticles Induces Inflammation and Perturbation of Trace Elements and Neurotransmitters, but Not Behavioral Impairment in Rats.” Environmental Science and Pollution Research International 25 (17): 16922–16932. doi:10.1007/s11356-018-1854-0.
  • Askri, D., S. Ouni, S. Galai, B. Chovelon, J. Arnaud, S. G. Lehmann, M. Sakly, et al. 2018b. “Sub-acute Intravenous Exposure to Fe2O3 Nanoparticles does not Alter Cognitive Performances and Catecholamine Levels, but Slightly Disrupts Plasma Iron Level and Brain Iron Content in Rats.” Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS) 50: 73–79. doi:10.1016/j.jtemb.2018.06.006.
  • Askri, D., S. Ouni, S. Galai, B. Chovelon, J. Arnaud, N. Sturm, S. G. Lehmann, et al. 2019a. “Nanoparticles in Foods? A Multiscale Physiopathological Investigation of Iron Oxide Nanoparticle Effects on Rats after an Acute Oral Exposure: Trace Element Biodistribution and Cognitive Capacities.” Food and Chemical Toxicology 127: 173–181. doi:10.1016/j.fct.2019.03.006.
  • Askri, D., V. Cunin, D. Béal, S. Berthier, B. Chovelon, J. Arnaud, W. Rachidi, et al. 2019b. “Investigating the Toxic Effects Induced by Iron Oxide Nanoparticles on Neuroblastoma Cell Line: An Integrative Study Combining Cytotoxic, Genotoxic and Proteomic Tools.” Nanotoxicology 13 (8): 1021–1040. doi:10.1080/17435390.2019.1621399.
  • Askri, D., V. Cunin, S. Ouni, D. Beal, W. Rachidi, M. Sakly, S. Amara, et al. 2019c. “Effects of Iron Oxide Nanoparticles (γ-Fe2O3) on Liver, Lung and Brain Proteomes following Sub-Acute Intranasal Exposure: A New Toxicological Assessment in Rat Model Using iTRAQ-Based Quantitative Proteomics.” International Journal of Molecular Sciences 20 (20): 5186. doi:10.3390/ijms20205186.
  • Awaad, A. 2015. “Histopathological and Immunological Changes Induced by Magnetite Nanoparticles in the Spleen, Liver and Genital Tract of Mice following Intravaginal Instillation.” Journal of Basic and Applied Zoology 71: 32–47. doi:10.1016/j.jobaz.2015.03.003.
  • Ayres-de-Campos, D. 2017. Obstetric Emergencies: A Practical Guide, edited by Ayres-de-Campos D, Vol. 1, 94, Chapter 2.1. Switzerland: Springer International Publishing. doi:10.1007/978-3-319-41656-4_2
  • Baratli, Y., A. L. Charles, V. Wolff, L. B. Tahar, L. Smiri, J. Bouitbir, J. Zoll, et al. 2014. “Age Modulates Fe3O4 Nanoparticles Liver Toxicity: Dose-Dependent Decrease in Mitochondrial Respiratory Chain Complexes Activities and Coupling in Middle-Aged as Compared to Young Rats.” Biomed Research International 2014: 1–10. doi:10.1155/2014/474081.
  • Baroli, B., M. G. Ennas, F. Loffredo, M. Isola, R. Pinna, and M. A. López-Quintela. 2007. “Penetration of Metallic Nanoparticles in Human Full-Thickness Skin.” The Journal of Investigative Dermatology 127 (7): 1701–1712. doi:10.1038/sj.jid.5700733.
  • Behzadi, S., V. Serpooshan, W. Tao, M. A. Hamaly, M. Y. Alkawareek, E. C. Dreaden, D. Brown, et al. 2017. “Cellular Uptake of Nanoparticles: Journey inside the Cell.” Chemical Society Reviews 46 (14): 4218–4244. doi:10.1039/c6cs00636a.
  • Berry, C. C., S. Charles, S. Wells, M. J. Dalby, and A. S. G. Curtis. 2004. “The Influence of Transferrin Stabilised Magnetic Nanoparticles on Human Dermal Fibroblasts in Culture.” International Journal of Pharmaceutics 269 (1): 211–225. doi:10.1016/j.ijpharm.2003.09.042.
  • Blank, F., P. Gerber, B. Rothen-Rutishauser, U. Sakulkhu, J. Salaklang, K. De Peyer, P. Gehr, et al. 2011. “Biomedical Nanoparticles Modulate Specific CD4+ T Cell Stimulation by Inhibition of Antigen Processing in Dendritic Cells.” Nanotoxicology 5 (4): 606–621. doi:10.3109/17435390.2010.541293.
  • Bobo, D., K. J. Robinson, J. Islam, K. J. Thurecht, and S. R. Corrie. 2016. “Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.” Pharmaceutical Research 33 (10): 2373–2387. doi:10.1007/s11095-016-1958-5.
  • Bohnen, M. S., G. Peng, S. H. Robey, C. Terrenoire, V. Iyer, K. J. Sampson, and R. S. Kass. 2017. “Molecular Pathophysiology of Congenital Long QT Syndrome.” Physiological Reviews 97 (1): 89–134. doi:10.1152/physrev.00008.2016.
  • Bostan, H. B., R. Rezaee, M. G. Valokala, K. Tsarouhas, K. Golokhvast, A. M. Tsatsakis, and G. Karimi. 2016. “Cardiotoxicity of Nano-particles.” Life Sciences 165: 91–99. doi:10.1016/j.lfs.2016.09.017.
  • Bourrinet, P., H. H. Bengele, B. Bonnemain, P. Bruno, A. Dencausse, J. M. Idee, M. P. Jacobs, and J. M. Lewis. 2006. “Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent.” Investigative Radiology 41 (3): 313–324. doi:10.1097/01.rli.0000197669.80475.dd.
  • Braet, F., E. Wisse, P. Bomans, P. Frederik, W. Geerts, A. Koster, L. Soon, et al. 2007. “Contribution of High-Resolution Correlative Imaging Techniques in the Study of the Liver Sieve in Three-Dimensions.” Microscopy Research and Technique 70 (3): 230–242. doi:10.1002/jemt.20408.
  • Brohi, Rahim Dad., Li Wang, Hira Sajjad Talpur, Di Wu, Farhan Anwar Khan, Dinesh Bhattarai, Zia-Ur Rehman, F. Farmanullah, and Li-Jun Huo. 2017. “Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review.” Frontiers in Pharmacology 8: 606. doi:10.3389/fphar.2017.00606.
  • Bynoe, M. S., C. Viret, A. Yan, and D. G. Kim. 2015. “Adenosine Receptor Signaling: A Key to Opening the Blood–Brain Door.” Fluids Barriers CNS 12: 20. doi:10.1186/s12987-015-0017-7.
  • Calderón-Garcidueñas, Lilian, Angélica González-Maciel, Partha S. Mukherjee, Rafael Reynoso-Robles, Beatriz Pérez-Guillé, Carlos Gayosso-Chávez, Ricardo Torres-Jardón, et al. 2019. “Combustion- and Friction-Derived Magnetic Air Pollution Nanoparticles in Human Hearts.” Environmental Research 176: 108567. doi:10.1016/j.envres.2019.108567.
  • Calderón-Garcidueñas, L., A. Herrera-Soto, N. Jury, B. A. Maher, A. González-Maciel, R. Reynoso-Robles, P. Ruiz-Rudolph, et al. 2020. “Reduced Repressive Epigenetic Marks, Increased DNA Damage and Alzheimer's Disease Hallmarks in the Brain of Humans and Mice Exposed to Particulate Urban Air Pollution.” Environmental Research 183: 109226. doi:10.1016/j.envres.2020.109226.
  • Caro, C., D. Egea-Benavente, R. Polvillo, J. L. Royo, M. P. Leal, and M. L. García-Martín. 2019. “Comprehensive Toxicity Assessment of PEGylated Magnetic Nanoparticles for in Vivo Applications.” Colloids and Surfaces. B: Biointerfaces 177: 253–259. doi:10.1016/j.colsurfb.2019.01.051.
  • Chahinez, T., R. Rachid, G. Salim, B. Lamia, Z. Ghozala, T. Nadjiba, S. Aya, et al. 2016. “Toxicity of Fe 3 O 4 Nanoparticles on Oxidative Stress Status, Stromal Enzymes and Mitochondrial Respiration and Swelling of Oryctolagus Cuniculus Brain Cortex.” Toxicology and Environmental Health Sciences 8 (5): 349–355. doi:10.1007/s13530-016-0296-7.
  • Chapel, J. M., M. D. Ritchey, D. Zhang, and G. Wang. 2017. “Prevalence and Medical Costs of Chronic Diseases among Adult Medicaid Beneficiaries.” American Journal of Preventive Medicine 53 (6S2): S143–S154. doi:10.1016/j.amepre.2017.07.019.
  • Choi, H. S., B. I. Ipe, P. Misra, J. H. Lee, M. G. Bawendi, and V. John. 2009. “Frangioni Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots.” Nano Letters 9 (6): 2354–2359. doi:10.1021/nl900872r.
  • Choudhury, Hira, Manisha Pandey, Pei Xin Chin, Yee Lin Phang, Jeng Yuen Cheah, Shu Chien Ooi, Kit-Kay Mak, et al. 2018. “Transferrin Receptors-Targeting Nanocarriers for Efficient Targeted Delivery and Transcytosis of Drugs into the Brain Tumors: A Review of Recent Advancements and Emerging Trends.” Drug Delivery and Translational Research 8 (5): 1545–1563. doi:10.1007/s13346-018-0552-2.
  • Cochran, D. B., P. P. Wattamwar, R. Wydra, J. Z. Hilt, K. W. Anderson, R. E. Eitel, and T. D. Dziubla. 2013. “Suppressing Iron Oxide Nanoparticle Toxicity by Vascular Targeted Antioxidant Polymer Nanoparticles.” Biomaterials 34 (37): 9615–9622. doi:10.1016/j.biomaterials.2013.08.025.
  • Conrad, M., and B. Proneth. 2019. “Broken Hearts: Iron Overload, Ferroptosis and Cardiomyopathy.” Cell Research 29 (4): 263–264. doi:10.1038/s41422-019-0150-y.
  • Corot, C., P. Robert, J. M. Idée, and M. Port. 2006. “Recent Advances in Iron Oxide Nanocrystal Technology for Medical Imaging.” Advanced Drug Delivery Reviews 58 (14): 1471–1504. doi:10.1016/j.addr.2006.09.013.
  • Crist, R. M., S. S. K. Dasa, C. H. Liu, J. D. Clogston, M. A. Dobrovolskaia, and S. T. Stern. 2020. “Challenges in the Development of Nanoparticle‐Based Imaging Agents: Characterization and Biology.” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology e1665. doi:10.1002/wnan.1665.
  • Cromer Berman, S. M., C. J. W. Kshitiz, I. Orukari, A. Levchenko, J. W. M. Bulte, and P. Walczak. 2013. “Cell Motility of Neural Stem Cells is Reduced after SPIO-Labeling, Which is Mitigated after Exocytosis.” Magnetic Resonance in Medicine 69 (1): 255–262. doi:10.1002/mrm.24216.
  • Crowe, T. P., M. H. W. Greenlee, A. G. Kanthasamy, and W. H. Hsu. 2018. “Mechanism of Intranasal Drug Delivery Directly to the Brain.” Life Sciences 195: 44–52. doi:10.1016/j.lfs.2017.12.025.
  • D’Agata, F., F. A. Ruffinatti, S. Boschi, I. Stura, I. Rainero, O. Abollino, et al. 2018. “Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues.” Molecules 23 (1): 9. doi:10.3390/molecules230100.
  • Dalpiaz, A., and B. Pavan. 2018. “Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?” Pharmaceutics 10 (2): 39. doi:10.3390/pharmaceutics10020039.
  • Dhakshinamoorthy, V., V. Manickam, and E. Perumal. 2017. “Neurobehavioural Toxicity of Iron Oxide Nanoparticles in Mice.” Neurotoxicity Research 32 (2): 187–203. doi:10.1007/s12640-017-9721-1.
  • Di Bona, K. R., Y. Xu, M. Gray, M. Gray, D. Fair, H. Hayles, L. Milad, et al. 2015. “Short- and Long-Term Effects of Prenatal Exposure to Iron Oxide Nanoparticles: Influence of Surface Charge and Dose on Developmental and Reproductive Toxicity.” International Journal of Molecular Sciences 16 (12): 30251–30268. doi:10.3390/ijms161226231.
  • Di Bona, K. R., Y. Xu, P. A. Ramirez, J. DeLaine, C. Parker, Y. Bao, and J. F. Rasco. 2014. “Surface Charge and Dosage Dependent Potential Developmental Toxicity and Biodistribution of Iron Oxide Nanoparticles in Pregnant CD-1 Mice.” Reproductive Toxicology (Elmsford, N.Y.) 50: 36–42. doi:10.1016/j.reprotox.2014.09.010.
  • Dias, A. M. G. C., A. Hussain, A. S. Marcos, and A. C. Roque. 2011. “A Biotechnological Perspective on the Application of Iron Oxide Magnetic Colloids Modified with Polysaccharides.” Biotechnology Advances 29 (1): 142–155. doi:10.1016/j.biotechadv.2010.10.003.
  • Dixon, S. J., K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev, C. E. Gleason, D. N. Patel, et al. 2012. “Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death.” Cell 149 (5): 1060–1072. doi:10.1016/j.cell.2012.03.042.
  • Drozdov, A. S., V. V. Vinogradov, I. P. Dudanov, and V. V. Vinogradov. 2016. “Leach-Proof Magnetic Thrombolytic Nanoparticles and Coatings of Enhanced Activity.” Scientific Reports 6: 28119. doi:10.1038/srep28119.
  • Drozdov, A. S., K. V. Volodina, V. V. Vinogradov, and V. V. Vinogradov. 2015. “Biocomposites for Wound-Healing Based on Sol–Gel Magnetite.” RSC Advances 5 (101): 82992–82997. doi:10.1039/C5RA16177K.
  • Du, B., M. Yu, and J. Zheng. 2018. “Transport and Interactions of Nanoparticles in the Kidneys.” Nature Reviews Materials 3 (10): 358–374. doi:10.1038/s41578-018-0038-3.
  • Du, Li-Jing, Kun Xiang, Jia-Hui Liu, Zheng-Mei Song, Yuanfang Liu, Aoneng Cao, and Haifang Wang. 2018. “Intestinal Injury Alters Tissue Distribution and Toxicity of ZnO Nanoparticles in Mice.” Toxicology Letters 295: 74–85. doi:10.1016/j.toxlet.2018.05.038.
  • Du, Rong-Hui, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, et al. 2020. “Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study.” European Respiratory Journal 55 (5): 2000524. doi:10.1183/13993003.00524-2020.
  • Dwivedi, S., M. A. Siddiqui, N. N. Farshori, M. Ahamed, J. Musarrat, and A. A. Al-Khedhairy. 2014. “Synthesis, Characterization and Toxicological Evaluation of Iron Oxide Nanoparticles in Human Lung Alveolar Epithelial Cells.” Colloids and Surfaces. B, Biointerfaces 122: 209–215. doi:10.1016/j.colsurfb.2014.06.064.
  • Einav, S., and M. Leone. 2019. “Epidemiology of Obstetric Critical Illness.” International Journal of Obstetric Anesthesia 40: 128–139. doi:10.1016/j.ijoa.2019.05.010.
  • Elgharabawy, R. M., D. M. Elgharbawy, and A. M. Emara. 2018. “Activation of the Molecular and Functional Effects of Nrf2 against Chronic Iron Oxide Nanorod Overload-Induced Cardiotoxicity.” Human & Experimental Toxicology 37 (8): 870–885. doi:10.1177/0960327117741751.
  • Engin, A. B., and A. Engin. 2019. “Nanoparticles and Neurotoxicity: Dual Response of Glutamatergic Receptors.” Progress in Brain Research 245: 281–303. doi:10.1016/bs.pbr.2019.03.005.
  • Facciolà, Alessio, Giuseppa Visalli, Sebastiano La Maestra, Manuela Ceccarelli, Francesco D'Aleo, Giuseppe Nunnari, Giovanni Francesco Pellicanò, et al. 2019. “Carbon Nanotubes and Central Nervous System: Environmental Risks, Toxicological Aspects and Future Perspectives.” Environmental Toxicology and Pharmacology 65: 23–30. doi:10.1016/j.etap.2018.11.006.
  • Fahmy, Heba M., Esraa M. Aly, Faten F. Mohamed, Neveen A. Noor, and Anwar A. Elsayed. 2020. “Neurotoxicity of Green-Synthesized Magnetic Iron Oxide Nanoparticles in Different Brain Areas of Wistar Rats.” Neurotoxicology 77: 80–93. doi:10.1016/j.neuro.2019.12.014.
  • Fakhardo, Anna F., Elizaveta I. Anastasova, Sabina R. Gabdullina, Anastasia S. Solovyeva, Valeria B. Saparova, Vladimir V. Chrishtop, Ekaterina D. Koshevaya, et al. 2019. “Toxicity Patterns of Clinically Relevant Metal Oxide Nanoparticles.” ACS Applied Bio Materials 2 (10): 4427–4435. doi:10.1021/acsabm.9b00615.
  • Fallahi, S., Z. Hooshmandi, and M. Setorki. 2017. “The Effects of Fe4NiO4Zn Nanoparticles on Thyroid Tissue and Serum Level of T3, T4 and TSH.” Journal of Shahrekord University of Medical Sciences 18 (6): 115–124. URL: http://journal.skums.ac.ir/article-1-2699-en.html.
  • Faust, J. J., W. Zhang, Y. Chen, and D. G. Capco. 2014. “Alpha-Fe(2)O(3) Elicits Diameter-Dependent Effects during Exposure to an in Vitro Model of the Human Placenta.” Cell Biology and Toxicology 30 (1): 31–53. doi:10.1007/s10565-013-9267-9.
  • Feng, Q., Y. Liu, J. Huang, K. Chen, J. Huang, and K. Xiao. 2018. “Uptake Distribution, Clearance, and Toxicity of Iron Oxide Nanoparticles with Different Sizes and Coatings.” Scientific Reports 8: 2082.
  • Fernández-Bertólez, N., C. Costa, F. Brandão, G. Kiliç, J. P. Teixeira, E. Pásaro, B. Laffon, et al. 2018. “Neurotoxicity Assessment of Oleic Acid-Coated Iron Oxide Nanoparticles in SH-SY5Y Cells.” Toxicology 406–407: 81–91. doi:10.1016/j.tox.2018.06.003.
  • Fernández-Bertólez, N., C. Costa, F. Brandão, J. A. Duarte, J. P. Teixeira, E. Pásaro, V. Valdiglesias, et al. 2019. “Evaluation of Cytotoxicity and Genotoxicity Induced by Oleic Acid-Coated Iron Oxide Nanoparticles in Human Astrocytes.” Environmental and Molecular Mutagenesis 60 (9): 816–829. doi:10.1002/em.22323.
  • Fernández-Real, J. M., and M. Manco. 2014. “Effects of Iron Overload on Chronic Metabolic Diseases.” The Lancet. Diabetes & Endocrinology 2 (6): 513–526. doi:10.1016/S2213-8587(13)70174-8.
  • Frtús, Adam, Barbora Smolková, Mariia Uzhytchak, Mariia Lunova, Milan Jirsa, Šárka Kubinová, Alexandr Dejneka, et al. 2020. “Analyzing the Mechanisms of Iron Oxide Nanoparticles Interactions with Cells: A Road from Failure to Success in Clinical Applications.” Journal of Controlled Release: Official Journal of the Controlled Release Society 328: 59–77. doi:10.1016/j.jconrel.2020.08.036.
  • Gabrielsen, J. S., D. J. Lamb, and L. I. Lipshultz. 2018. “Iron and a Man's Reproductive Health: The Good, the Bad, and the Ugly.” Current Urology Reports 19 (8): 60. doi:10.1007/s11934-018-0808-x.
  • Gaharwar, U. S., R. Meena, and P. Rajamani. 2019. “Biodistribution, Clearance and Morphological Alterations of Intravenously Administered Iron Oxide Nanoparticles in Male Wistar Rats.” International Journal of Nanomedicine 14: 9677–9692. doi:10.2147/IJN.S223142.
  • Gazibara, T., T. Pekmezović, A. Popović, M. Paunić, and D. Kisić-Tepavčević. 2018. “Chronic Diseases among University Students: Prevalence, Patterns and Impact on Health-Related Quality of Life.” Vojnosanitetski Pregled 75 (12): 1178–1184. doi:10.2298/VSP160920050G.
  • Ghadiri, M., E. Vasheghani‐Farahani, F. Atyabi, F. Kobarfard, F. Mohamadyar‐Toupkanlou, and H. Hosseinkhani. 2017. “Transferrin-Conjugated Magnetic Dextran-Spermine Nanoparticles for Targeted Drug Transport cross Blood–Brain Barrier.” Journal of Biomedical Materials Research. Part A 105 (10): 2851–2864. doi:10.1002/jbm.a.36145.
  • Giannopoulou, I., M. A. Pagida, D. D. Briana, and M. T. Panayotacopoulou. 2018. “Perinatal Hypoxia as a Risk Factor for Psychopathology Later in Life: The Role of Dopamine and Neurotrophins.” Hormones (Athens, Greece) 17 (1): 25–32. doi:10.1007/s42000-018-0007-7.
  • Gómez-Vallejo, V., M. Puigivila, S. Plaza-García, B. Szczupak, R. Piñol, J. L. Murillo, V. Sorribas, et al. 2018.“ PEG-Copolymer-Coated Iron Oxide Nanoparticles that Avoid the Reticuloendothelial System and Act as Kidney MRI Contrast Agents.” Nanoscale 10 (29): 14153–14164. doi:10.1039/c8nr03084g.
  • Gonnissen, D., Y. Qu, K. Langer, C. Öztürk, Y. Zhao, C. Chen, G. Seebohm, et al. 2016. “Comparison of Cellular Effects of Starch-Coated SPIONs and Poly(Lactic-co-Glycolic Acid) Matrix Nanoparticles on Human Monocytes.” International Journal of Nanomedicine 11: 5221–5236. doi:10.2147/IJN.S106540.
  • González-Maciel, A., R. Reynoso-Robles, R. Torres-Jardón, P. S. Mukherjee, and L. Calderón-Garcidueñas. 2017. “Combustion-Derived Nanoparticles in Key Brain Target Cells and Organelles in Young Urbanites: Culprit Hidden in Plain Sight in Alzheimer's Disease Development.” Journal of Alzheimer's Disease 59 (1): 189–208. doi:10.3233/JAD-170012.
  • Gu, L., R. H. Fang, M. J. Sailor, and J. H. Park. 2012. “In Vivo Clearance and Toxicity of Monodisperse Iron Oxide Nanocrystals.” ACS Nano 6 (6): 4947–4954. doi:10.1021/nn300456z.
  • Gualdani, R., A. Guerrini, E. Fantechi, F. Tadini-Buoninsegni, M. R. Moncelli, and C. Sangregorio. 2019. “Superparamagnetic Iron Oxide Nanoparticles (SPIONs) Modulate hERG Ion Channel Activity.” Nanotoxicology 13 (9): 1197–1209. doi:10.1080/17435390.2019.1650969.
  • Hamm, B., T. Staks, M. Taupitz, R. Maibauer, A. Speidel, A. Huppertz, T. Frenzel, et al. 1994. “Contrast-Enhanced MR Imaging of Liver and Spleen: First Experience in Humans with a New Superparamagnetic Iron Oxide.” Journal of Magnetic Resonance Imaging 4 (5): 659–668. doi:10.1002/jmri.1880040508.
  • Hanini, A., A. Schmitt, K. Kacem, F. Chau, S. Ammar, and J. Gavard. 2011. “Evaluation of Iron Oxide Nanoparticle Biocompatibility.” International Journal of Nanomedicine 6: 787–794. doi:10.2147/IJN.S17574.
  • Harisinghani, M. G., J. Barentsz, P. F. Hahn, W. M. Deserno, S. Tabatabaei, C. H. van de Kaa, J. de la Rosette, et al. 2003. “Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer.” New England Journal of Medicine 348 (25): 2491–2499. doi:10.1056/NEJMoa022749.
  • Harris, J. M., and R. B. Chess. 2003. “Effect of Pegylation on Pharmaceuticals.” Nature Reviews. Drug Discovery 2 (3): 214–221. doi:10.1038/nrd1033.
  • Hasan, A., M. Morshed, A. Memic, S. Hassan, T. J. Webster, and H. E. Marei. 2018. “Nanoparticles in Tissue Engineering: Applications, Challenges and Prospects.” International Journal of Nanomedicine 13: 5637–5655. doi:10.2147/IJN.S153758.
  • He, Q., Z. Zhang, F. Gao, Y. Li, and J. Shi. 2011. “In Vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation.” Small (Weinheim an Der Bergstrasse, Germany) 7 (2): 271–280. doi:10.1002/smll.201001459.
  • Hossen, S., M. K. Hossain, M. K. Basher, M. N. H. Mia, M. T. Rahman, and M. J. Uddin. 2019. “Smart Nanocarrier-Based Drug Delivery Systems for Cancer Therapy and Toxicity Studies: A Review.” Journal of Advanced Research 15: 1–18. doi:10.1016/j.jare.2018.06.005.
  • Hou, C. C., and J. Q. Zhu. 2017. “Nanoparticles and Female Reproductive System: How Do Nanoparticles Affect Oogenesis and Embryonic Development.” Oncotarget 8 (65): 109799–109817. doi:10.18632/oncotarget.19087.
  • Hou, W., Y. Xie, X. Song, X. Sun, M. T. Lotze, H. J. Zeh, III, R. Kang, et al. 2016. “Autophagy Promotes Ferroptosis by Degradation of Ferritin.” Autophagy 12 (8): 1425–1428. doi:10.1080/15548627.2016.1187366.
  • Huang, C. C., C. Y. Tsai, H. S. Sheu, K. Y. Chuang, C. H. Su, U. S. Jeng, F. Y. Cheng, et al. 2011. “Enhancing Transversal Relaxation for Magnetite Nanoparticles in MR Imaging Using Gd³+- Chelated Mesoporous Silica Shells.” ACS Nano 5 (5): 3905–3916. doi:10.1021/nn200306g.
  • Huo, T., Y. Jia, C. Yin, X. Luo, J. Zhao, Z. Wang, and P. Lv. 2019. “Iron Dysregulation in Vascular Dementia: Focused on the AMPK/Autophagy Pathway.” Brain Research Bulletin 153: 305–313. doi:10.1016/j.brainresbull.2019.09.006.
  • Hussain, S. M., K. L. Hess, J. M. Gearhart, K. T. Geiss, and J. J. Schlager. 2005. “In Vitro Toxicity of Nanoparticles in BRL 3A Rat Liver Cells.” Toxicology in Vitro : An International Journal Published in Association with BIBRA 19 (7): 975–983. doi:10.1016/j.tiv.2005.06.034.
  • Imam, S. Z., S. M. Lantz-McPeak, E. Cuevas, H. Rosas-Hernandez, S. Liachenko, Y. Zhang, S. Sarkar, et al. 2015. “Iron Oxide Nanoparticles Induce Dopaminergic Damage: In Vitro Pathways and in Vivo Imaging Reveals Mechanism of Neuronal Damage.” Molecular Neurobiology 52 (2): 913–926. doi:10.1007/s12035-015-9259-2.
  • Jacobsen, Tove F., Michael Laniado, Bernard E. Van Beers, Benoit Dupas, Frank P. Boudghène, Ernst Rummeny, Theo H. M. Falke, Peter A. Rinck, David MacVicar, and Bjørg Lundby. 1996. “Oral Magnetic Particles (Ferristene) as a Contrast Medium in Abdominal Magnetic Resonance Imaging.” Academic Radiology 3 (7): 571–580. doi:10.1016/S1076-6332(96)80222-4.
  • Jeng, H. A., and J. Swanson. 2006. “Toxicity of Metal Oxide Nanoparticles in Mammalian Cells.” Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering 41 (12): 2699–2711. doi:10.1080/10934520600966177.
  • Jensen, V. S., T. Porsgaard, J. Lykkesfeldt, and H. Hvid. 2016. “Rodent Model Choice Has Major Impact on Variability of Standard Preclinical Readouts Associated with Diabetes and Obesity Research.” American Journal of Translational Research 8 (8): 3574–3584.
  • Jiang, Ziyu, Kuizhong Shan, Jie Song, Jingbing Liu, Suresh Rajendran, Arivalagan Pugazhendhi, Joe Antony Jacob, and Baoan Chen. 2019. “Toxic Effects of Magnetic Nanoparticles on Normal Cells and Organs.” Life Sciences 220: 156–161. doi:10.1016/j.lfs.2019.01.056.
  • Jung, E., X. Hui, H. Zhu, A. Zhang, W. Wang, B. Buchholz, and H. Maibach. 2019. “Effect of Iron and Silica Nanoparticles’ Size on in Vitro Human Skin Binding and Penetration.” Toxicology Research and Application 3:1–10. doi:10.1177/2397847319893054.
  • Karlsson, H. L., J. Gustafsson, P. Cronholm, and L. Möller. 2009. “Size-Dependent Toxicity of Metal Oxide Particles – A Comparison between Nano- and Micrometer Size.” Toxicology Letters 188 (2): 112–118. doi:10.1016/j.toxlet.2009.03.014.
  • Karmakar, A., Q. Zhang, and Y. Zhang. 2014. “Neurotoxicity of Nanoscale Materials.” Journal of Food and Drug Analysis 22 (1): 147–160. doi:10.1016/j.jfda.2014.01.012.
  • Katsnelson, Boris A., Tamara D. Degtyareva, Ilzira I. Minigalieva, Larisa I. Privalova, Sergey V. Kuzmin, Olga S. Yeremenko, Ekaterina P. Kireyeva, et al. 2011. “Subchronic Systemic Toxicity and Bioaccumulation of Fe3O4 Nano- and Microparticles following Repeated Intraperitoneal Administration to Rats.” International Journal of Toxicology 30 (1): 59–68., doi: 10.1016/j.toxrep.2018.03.008.
  • Kazemipour, N., S. Nazifi, M. H. H. Poor, Z. Esmailnezhad, R. E. Najafabadi, and E. Abolghasem. 2018. “Hepatotoxicity and Nephrotoxicity of Quercetin, Iron Oxide Nanoparticles, and Quercetin Conjugated with Nanoparticles in Rats.” Comparative Clinical Pathology 27 (6): 1621–1628. doi:10.1007/s00580-018-2783-5.
  • Kedziorek, D. A., N. Muja, P. Walczak, J. Ruiz-Cabello, A. A. Gilad, C. C. Jie, and W. Jeff. 2010. “Gene Expression Profiling Reveals Early Cellular Responses to Intracellular Magnetic Labeling with Superparamagnetic Iron Oxide Nanoparticles.” Magnetic Resonance in Medicine 63 (4): 1031–1043. doi:10.1002/mrm.22290.
  • Kermanizadeh, A., N. R. Jacobsen, M. Roursgaard, S. Loft, and P. Møller. 2017. “Hepatic Hazard Assessment of Silver Nanoparticle Exposure in Healthy and Chronically Alcohol Fed Mice.” Toxicological Sciences : An Official Journal of the Society of Toxicology 158 (1): 176–187. doi:10.1093/toxsci/kfx080.
  • Khan, A. R., M. Liu, M. W. Khan, and G. Zhai. 2017. “Progress in Brain Targeting Drug Delivery System by Nasal Route.” Journal of Controlled Release : Official Journal of the Controlled Release Society 268: 364–389. doi:10.1016/j.jconrel.2017.09.001.
  • Kiliç, G., N. Fernández-Bertólez, C. Costa, F. Brandão, J. P. Teixeira, E. Pásaro, B. Laffon, et al. 2017. “Chapter 6 – The Application, Neurotoxicity, and Related Mechanism of Iron Oxide Nanoparticles.” Neurotoxicity of Nanomaterials and Nanomedicine, 127–150. New York, NY: Elsevier. doi:10.1016/B978-0-12-804598-5.00006-4..
  • Kim, B. G., M. K. Park, P. H. Lee, S. H. Lee, J. Hong, M. M. M. Aung, K. T. Moe, et al. 2020. “Effects of Nanoparticles on Neuroinflammation in a Mouse Model of Asthma.” Respiratory Physiology & Neurobiology 271: 103292. doi:10.1016/j.resp.2019.103292.
  • Kim, J. S., T. J. Yoon, K. N. Yu, K. N. Yu, B. G. Kim, S. J. Park, H. W. Kim, et al. 2006. “Toxicity and Tissue Distribution of Magnetic Nanoparticles in Mice.” Toxicological Sciences : An Official Journal of the Society of Toxicology 89 (1): 338–347. doi:10.1093/toxsci/kfj027.
  • Kirschvink, J. L., A. Kobayashi-Kirschvink, and B. J. Woodford. 1992. “Magnetite Biomineralization in the Human Brain.” Proceedings of the National Academy of Sciences of the United States of America 89 (16): 7683–7687. doi:10.1073/pnas.89.16.7683.
  • Knorr, F., A. Patzelt, M. C. Meinke, A. Vogt, U. Blume-Peytavi, E. Rühl, and J. Lademann. 2019. “Interactions of Nanoparticles with Skin.” In Biological Responses to Nanoscale Particles, edited by P. Gehr, and R. Zellner, 329–339. Cham: Springer. doi:10.1007/978-3-030-12461-8_13.
  • Kodali, V., M. H. Littke, S. C. Tilton, J. G. Teeguarden, L. Shi, C. W. Frevert, W. Wang, et al. 2013. “Dysregulation of Macrophage Activation Profiles by Engineered Nanoparticles.” ACS Nano 7 (8): 6997–7010. doi:10.1021/nn402145t.
  • Kolosnjaj-Tabi, J., Y. Javed, L. Lartigue, J. Volatron, D. Elgrabli, I. Marangon, G. Pugliese, et al. 2015. “The One Year Fate of Iron Oxide Coated Gold Nanoparticles in Mice.” ACS Nano 9 (8): 7925–7939. doi:10.1021/acsnano.5b00042.
  • Kornberg, T. G., T. A. Stueckle, J. A. Antonini, Y. Rojanasakul, V. Castranova, Y. Yang, and L. Wang. 2017. “Potential Toxicity and Underlying Mechanisms Associated with Pulmonary Exposure to Iron Oxide Nanoparticles: Conflicting Literature and Unclear Risk.” Nanomaterials (Basel) 7 (10): 307. doi:10.3390/nano7100307.
  • Kumari, M., S. Rajak, S. P. Singh, S. I. Kumari, P. U. Kumar, U. S. N. Murty, M. Mahboob, et al. 2012. “Repeated Oral Dose Toxicity of Iron Oxide Nanoparticles: Biochemical and Histopathological Alterations in Different Tissues of Rats.” Journal of Nanoscience and Nanotechnology 12 (3): 2149–2159. doi:10.1166/jnn.2012.5796.
  • Kumari, M., S. Rajak, S. P. Singh, U. S. N. Murty, M. Mahboob, P. Grover, and M. F. Rahman. 2013. “Biochemical Alterations Induced by Acute Oral Doses of Iron Oxide Nanoparticles in Wistar Rats.” Drug and Chemical Toxicology 36 (3): 296–305. doi:10.3109/01480545.2012.720988.
  • Kunzmann, A., B. Andersson, C. Vogt, N. Feliu, F. Ye, S. Gabrielsson, M. S. Toprak, et al. 2011. “Efficient Internalization of Silica-Coated Iron Oxide Nanoparticles of Different Sizes by Primary Human Macrophages and Dendritic Cells.” Toxicology and Applied Pharmacology 253 (2): 81–93. doi:10.1016/j.taap.2011.03.011.
  • Kwon, D., H. W. Nho, and T. H. Yoon. 2014. “X-Ray and Electron Microscopy Studies on the Biodistribution and Biomodification of Iron Oxide Nanoparticles in Daphnia Magna.” Colloids and Surfaces. B, Biointerfaces 122: 384–389. doi:10.1016/j.colsurfb.2014.07.016.
  • Laffon, B., N. Fernández-Bertólez, C. Costa, F. Brandão, J. P. Teixeira, E. Pásaro, and V. Valdiglesias. 2018. “Cellular and Molecular Toxicity of Iron Oxide Nanoparticles.” Advances in Experimental Medicine and Biology 1048: 199–213. doi:10.1007/978-3-319-72041-8_12.
  • Lanks, C. W., A. I. Musani, and D. W. Hsia. 2019. “Community-Acquired Pneumonia and Hospital-Acquired Pneumonia.” The Medical Clinics of North America 103 (3): 487–501. doi:10.1016/j.mcna.2018.12.008.
  • Laurent, S., S. Dutz, U. O. Häfeli, and M. Mahmoudi. 2011. “Magnetic Fluid Hyperthermia: Focus on Superparamagnetic Iron Oxide Nanoparticles.” Advances in Colloid and Interface Science 166 (1–2): 8–23. doi:10.1016/j.cis.2011.04.003.
  • Lei, C., Y. Sun, D. C. W. Tsang, and D. Lin. 2018. “Environmental Transformations and Ecological Effects of Iron-Based Nanoparticles.” Environmental Pollution (Barking, Essex : 1987) 232: 10–30. doi:10.1016/j.envpol.2017.09.052.
  • Leichtmann-Bardoogo, Y., L. A. Cohen, A. Weiss, B. Marohn, S. Schubert, A. Meinhardt, and E. G. Meyron-Holtz. 2012. “Compartmentalization and Regulation of Iron Metabolism Proteins Protect Male Germ Cells from Iron Overload.” American Journal of Physiology-Endocrinology and Metabolism 302 (12): 1519–1530. doi:10.1152/ajpendo.00007.2012.
  • Lewinski, N., V. Colvin, and R. Drezek. 2008. “Cytotoxicity of Nanoparticles.” Small (Weinheim an Der Bergstrasse, Germany) 4 (1): 26–49. doi:10.1002/smll.200700595.
  • Lin, Y., C. Hu, A. Chen, X. Feng, H. Liang, S. Yin, G. Zhang, et al. 2020. “Neurotoxicity of Nanoparticles Entering the Brain via Sensory Nerve-to-Brain Pathways: Injuries and Mechanisms.” Archives of Toxicology 94 (5): 1479–1495. doi:10.1007/s00204-020-02701.
  • Liu, Y., J. Li, K. Xu, J. Gu, L. Huang, L. Zhang, N. Liu, et al. 2018. “Characterization of Superparamagnetic Iron Oxide Nanoparticle-Induced Apoptosis in PC12 Cells and Mouse Hippocampus and Striatum.” Toxicology Letters 292: 151–161. doi:10.1016/j.toxlet.2018.04.033.
  • Maher, B. A., A. González-Maciel, R. Reynoso-Robles, R. Torres-Jardón, and L. Calderón-Garcidueñas. 2020. “Iron-Rich Air Pollution Nanoparticles: An Unrecognised Environmental Risk Factor for Myocardial Mitochondrial Dysfunction and Cardiac Oxidative Stress.” Environmental Research 188: 109816. doi:10.1016/j.envres.2020.109816.
  • Maher, B. A., I. A. Ahmed, V. Karloukovski, D. A. MacLaren, P. G. Foulds, D. Allsop, D. M. A. Mann, et al. 2016. “Magnetite Pollution Nanoparticles in the Human Brain.” Proceedings of the National Academy of Sciences 113 (39): 10797–10801. doi:10.1073/pnas.1605941113.
  • Manickam, V., V. Dhakshinamoorthy, and E. Perumal. 2018. “Iron Oxide Nanoparticles Induces Cell Cycle-Dependent Neuronal Apoptosis in Mice.” Journal of Molecular Neuroscience 64 (3): 352–362. doi:10.1007/s12031-018-1030-5.
  • Manickam, V., V. Dhakshinamoorthy, and E. Perumal. 2019. “Iron Oxide Nanoparticles Affects Behaviour and Monoamine Levels in Mice.” Neurochemical Research 44 (7): 1533–1548. doi:10.1007/s11064-019-02774-9.
  • Masselli, G., and G. Gualdi. 2012. “MR Imaging of the Small Bowel.” Radiology 264 (2): 333–348. doi:10.1148/radiol.12111658.
  • McCulley, L., K. Gelperin, S. Bird, S. Harris, C. Wang, and P. Waldron. 2016. “Reports to FDA of Fatal Anaphylaxis Associated with Intravenous Iron Products.” American Journal of Hematology 91 (12): E496–E497. doi:10.1002/ajh.24531.
  • Mesárošová, M., K. Kozics, A. Bábelová, E. Regendová, M. Pastorek, D. Vnuková, B. Buliaková, et al. 2014. “The Role of Reactive Oxygen Species in the Genotoxicity of Surface-Modified Magnetite Nanoparticles.” Toxicology Letters 226 (3): 303–313. doi:10.1016/j.toxlet.2014.02.025.
  • Mohammadpour, R., M. A. Dobrovolskaia, D. L. Cheney, K. F. Greish, and H. Ghandehari. 2019. “Subchronic and Chronic Toxicity Evaluation of Inorganic Nanoparticles for Delivery Applications.” Advanced Drug Delivery Reviews 144: 112–132. doi:10.1016/j.addr.2019.07.00.
  • Morgan, J., R. Bell, and A. L. Jones. 2020. “Endogenous Doesn't Always Mean Innocuous: A Scoping Review of Iron Toxicity by Inhalation.” Journal of Toxicology and Environmental Health. Part B, Critical Reviews 23 (3): 107–136. doi:10.1080/10937404.2020.1731896.
  • Mou, X., Z. Ali, S. Li, and N. He. 2015. “Applications of Magnetic Nanoparticles in Targeted Drug Delivery System.” Journal of Nanoscience and Nanotechnology 15 (1): 54–62. doi:10.1166/jnn.2015.9585.
  • Mourabit, S., J. A. Fitzgerald, R. P. Ellis, A. Takesono, C. S. Porteus, M. Trznadel, J. Metz, et al. 2019. “New Insights into Organ-Specific Oxidative Stress Mechanisms Using a Novel Biosensor Zebrafish.” Environment International 133 (Pt A): 105138. doi:10.1016/j.envint.2019.105138.
  • Mulens-Arias, V., J. M. Rojas, L. Sanz-Ortega, Y. Portilla, S. Pérez-Yagüe, and D. F. Barber. 2019. “ Polyethylenimine-coated Superparamagnetic Iron Oxide Nanoparticles Impair In Vitro and In Vivo Angiogenesis .” Nanomedicine : Nanotechnology, Biology, and Medicine 21: 102063. doi:10.1016/j.nano.2019.102063.
  • Mushtaq, G., Khan, J. A., E. Joseph, J. Ebenezer, and A. Kamal Mohammad. 2015. “Nanoparticles, Neurotoxicity and Neurodegenerative Diseases.” Current Drug Metabolism 16 (8): 676–684. doi:10.2174/1389200216666150812122302.
  • Naqvi, S., M. Samim, M. Abdin, F. J. Ahmed, A. N. Maitra, C. K. Prashant, and A. K. Dinda. 2010. “Concentration-Dependent Toxicity of Iron Oxide Nanoparticles Mediated by Increased Oxidative Stress.” International Journal of Nanomedicine 5: 983–989. doi:10.2147/IJN.S13244.
  • Naumenko, V., A. A. Nikitin, K. Kapitanova, P. A. Melnikov, S. S. Vodopyanov, A. Garanina, M. Valikhov, et al. 2019. “Intravital Microscopy Reveals a Novel Mechanism of Nanoparticles Excretion in Kidney.” Journal of Controlled Release: Official Journal of the Controlled Release Society 100: 1–1. doi:10.1016/j.jconrel.2019.06.026.
  • Nemmar, A., S. Beegam, P. Yuvaraju, J. Yasin, S. Tariq, S. Attoub, and B. H. Ali. 2016. “Ultrasmall Superparamagnetic Iron Oxide Nanoparticles Acutely Promote Thrombosis and Cardiac Oxidative Stress and DNA Damage in Mice Part.” Particle and Fibre Toxicology 13 (1): 22. doi:10.1186/s12989-016-0132-x.
  • Ng, S. W., S. G. Norwitz, and E. R. Norwitz. 2019. “The Impact of Iron Overload and Ferroptosis on Reproductive Disorders in Humans: Implications for Preeclampsia.” International Journal of Molecular Sciences 20 (13): 3283. doi:10.3390/ijms20133283.
  • Noori, A., K. Parivar, M. Modaresi, M. Messripour, M. H. Yousefi, and R. G. 2011. “Amiri Effect of Magnetic Iron Oxide Nanoparticles on Pregnancy and Testicular Development of Mice Afr.” Journal of Biotechnology 10: 1221–1227. doi:10.1016/J.CLINBIOCHEM.2011.08.796.
  • Nosrati, Hamed, Mahsa Tarantash, Shayesteh Bochani, Jalil Charmi, Zahra Bagheri, Mohammadjavad Fridoni, Mohammad-Amin Abdollahifar, et al. 2019. “Glutathione (GSH) Peptide Conjugated Magnetic Nanoparticles as Blood–Brain Barrier Shuttle for Mri-Monitored Brain Delivery of Paclitaxel.” ACS Biomaterials Science & Engineering 5 (4): 1677–1685. doi:10.1021/acsbiomaterials.8b01420.
  • Nuzhina, J. V., A. A. Shtil, A. Y. Prilepskii, and V. V. Vinogradov. 2019. “Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines.” Journal of Drug Delivery Science and Technology 54: 101282. doi:10.1016/j.jddst.2019.101282.
  • Oberdörster, G., V. Stone, and K. Donaldson. 2007. “Toxicology of Nanoparticles: A Historical Perspective.” Nanotoxicology 1 (1): 2–25. doi:10.1080/17435390701314761.
  • Oliveira, V. R., J. J. Uriarte, B. Falcones, I. Jorba, W. A. Zin, R. Farré, D. Navajas, et al. 2019. “Biomechanical Response of Lung Epithelial Cells to Iron Oxide and Titanium Dioxide Nanoparticles.” Frontiers in Physiology 10: 1047. doi:10.3389/fphys.2019.01047.
  • Onishi, H., T. Murakami, T. Kim, M. Hori, S. Hirohashi, M. Matsuki, Y. Narumi, et al. 2009. “Safety of Ferucarbotran in MR Imaging of the Liver: A Pre- and Postexamination Questionnaire-Based Multicenter Investigation.” Journal of Magnetic Resonance Imaging 29 (1): 106–111. doi:10.1002/jmri.21608.
  • Paik, S. Y., J. S. Kim, S. J. Shin, and S. Ko. 2015. “Characterization, Quantification, and Determination of the Toxicity of Iron Oxide Nanoparticles to the Bone Marrow Cells.” International Journal of Molecular Sciences 16 (9): 22243–22257. doi:10.3390/ijms160922243.
  • Park, E. J., D. H. Choi, Y. Kim, E. W. Lee, J. Song, M. H. Cho, J. H. Kim, et al. 2014. “Magnetic Iron Oxide Nanoparticles Induce Autophagy Preceding Apoptosis through Mitochondrial Damage and ER Stress in RAW264.7 Cells.” Toxicology in Vitro : An International Journal Published in Association with BIBRA 28 (8): 1402–1412. doi:10.1016/j.tiv.2014.07.010.
  • Park, E. J., and K. Park. 2009. “Oxidative Stress and Pro-inflammatory Responses Induced by Silica Nanoparticles In Vivo and In Vitro.” Toxicology Letters 184 (1): 18–25. doi:10.1016/j.toxlet.2008.10.012.
  • Park, E. J., U. Jeong, Y. Kim, B. S. Lee, M. H. Cho, and Y. S. Go. 2017. “Deleterious Effects in Reproduction and Developmental Immunity Elicited by Pulmonary Iron Oxide Nanoparticles.” Environmental Research 152: 503–513. doi:10.1016/j.envres.2016.08.025.
  • Patel, S., S. Jana, R. Chetty, S. Thakore, M. Singh, and R. Devkar. 2019. “Toxicity Evaluation of Magnetic Iron Oxide Nanoparticles Reveals Neuronal Loss in Chicken Embryo.” Drug and Chemical Toxicology 42 (1): 1–8. doi:10.1080/01480545.2017.1413110.
  • Patzelt, A., and J. Lademann. 2020. “Recent Advances in Follicular Drug Delivery of Nanoparticles.” Expert Opinion on Drug Delivery 17 (1): 49–60. doi:10.1080/17425247.2020.1700226.
  • Pedram, M. Z., A. Shamloo, A. Alasty, and E. Ghafar-Zadeh. 2016. “Optimal Magnetic Field for Crossing Super-Para-Magnetic Nanoparticles through the Brain Blood Barrier: A Computational Approach.” Biosensors 6 (2): 25. doi:10.3390/bios6020025.
  • Pedro, L., Q. Harmer, E. Mayes, and J. D. Shields. 2019. “Impact of Locally Administered Carboxydextran-Coated Super-Paramagnetic Iron Nanoparticles on Cellular Immune Function.” Small 15 (20): 1900224. doi:10.1002/smll.201900224.
  • Periasamy, V. S., J. Athinarayanan, M. Alhazmi, K. A. Alatiah, and A. A. Alshatwi. 2016. “Fe3 O4 Nanoparticle Redox System Modulation Via Cell-Cycle Progression and Gene Expression in Human Mesenchymal Stem Cells.” Environmental Toxicology 31 (8): 901–912. doi:10.1002/tox.22098.
  • Peto, M. V. 2010. “Aluminium and Iron in Humans: Bioaccumulation, Pathology, and Removal.” Rejuvenation Research 13 (5): 589–598. doi:10.1089/rej.2009.0995.
  • Petters, C., E. Irrsack, M. Koch, and R. Dringen. 2014. “Uptake and Metabolism of Iron Oxide Nanoparticles in Brain Cells.” Neurochemical Research 39 (9): 1648–1660. doi:10.1007/s11064–014-1380-5.
  • Pilakka-Kanthikeel, S., V. S. R. Atluri, V. Sagar, S. K. Saxena, and M. Nair. 2013. “Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood–Brain Barrier for Neuro-protection Using Magnetic Nano Carriers: An In-Vitro Study.” PLoS One 8 (4): e62241. doi:10.1371/journal.pone.0062241.
  • Pollock, W., L. Rose, and C. L. Dennis. 2010. “Pregnant and Postpartum Admissions to the Intensive Care Unit: A Systematic Review.” Intensive Care Medicine 36 (9): 1465–1474. doi:10.1007/s00134–010-1951-0.
  • Pongrac, I. M., M. Dobrivojević, L. B. Ahmed, M. Babič, M. Šlouf, D. Horák, and S. Gajović. 2016. “Improved Biocompatibility and Efficient Labeling of Neural Stem Cells with Poly(L-Lysine)-Coated Maghemite Nanoparticles.” Beilstein Journal of Nanotechnology 7: 926–936. doi:10.3762/bjnano.7.84.
  • Prilepskii, Artur Y., Anna F. Fakhardo, Andrey S. Drozdov, Vasiliy V. Vinogradov, Ivan P. Dudanov, Alexander A. Shtil, Petr P. Bel'tyukov, et al. 2018. “Urokinase-Conjugated Magnetite Nanoparticles as a Promising Drug Delivery System for Targeted Thrombolysis: Synthesis and Preclinical Evaluation.” ACS Applied Materials & Interfaces 10 (43): 36764–36775. doi:10.1021/acsami.8b14790.
  • Raghupathi, W., and V. Raghupathi. 2018. “An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health.” International Journal of Environmental Research and Public Health 15 (3): 431. doi:10.3390/ijerph15030431.
  • Rahman, I., S. K. Biswas, and P. A. Kirkham. 2006. “Regulation of Inflammation and Redox Signaling by Dietary Polyphenols.” Biochemical Pharmacology 72 (11): 1439–1452. doi:10.1016/j.bcp.2006.07.004.
  • Reddy, U. A., P. Prabhakar, and M. Mahboob. 2017. “Biomarkers of Oxidative Stress for in Vivo Assessment of Toxicological Effects of Iron Oxide Nanoparticles.” Saudi Journal of Biological Sciences 24 (6): 1172–1180. doi:10.1016/j.sjbs.2015.09.029.
  • Remya, N. S., S. Syama, A. Sabareeswaran, and P. V. Mohanan. 2016. “Toxicity, Toxicokinetics and Biodistribution of Dextran Stabilized Iron Oxide Nanoparticles for Biomedical Applications.” International Journal of Pharmaceutics 511 (1): 586–598. doi:10.1016/j.ijpharm.2016.06.119.
  • Richards, J. M. J., C. A. Shaw, N. N. Lang, M. C. Williams, S. I. K. Semple, T. J. MacGillivray, C. Gray, et al. 2012. “In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans.” Circulation. Cardiovascular Imaging 5 (4): 509–517. doi:10.1161/CIRCIMAGING.112.972596.
  • Robinson, J. G., K. M. Fox, M. F. Bullano, and S. Grandy,; S. S. Group. 2009. “Atherosclerosis Profile and Incidence of Cardiovascular Events: A Population-Based Survey.” BMC Cardiovascular Disorders 9 (1): 46. doi:10.1186/1471-2261-9-46.
  • Rojas, J. M., L. Sanz-Ortega, V. Mulens-Arias, L. Gutiérrez, S. Pérez-Yagüe, and D. F. Barber. 2016. “Superparamagnetic Iron Oxide Nanoparticle Uptake Alters M2 Macrophage Phenotype, Iron Metabolism, Migration and Invasion.” Nanomedicine : Nanotechnology, Biology, and Medicine 12 (4): 1127–1138. doi:10.1016/j.nano.2015.11.020.
  • Sadauskas, E., H. Wallin, M. Stoltenberg, U. Vogel, P. Doering, A. Larsen, and G. Danscher. 2007. “Kupffer Cells Are Central in the Removal of Nanoparticles from the Organism.” Particle and Fibre Toxicology 4: 10. doi:10.1186/1743–8977-4-10.
  • Sadeghi, L., B. V. Yousefi, and H. R. Espanani. 2015. “Toxic Effects of the Fe2O3 Nanoparticles on the Liver and Lung Tissue.” Bratislavske Lekarske Listy 116 (6): 373–378. doi:10.4149/bll_2015_071.
  • Saijo, K., and C. K. Glass. 2011. “Microglial Cell Origin and Phenotypes in Health and Disease.” Nature Reviews. Immunology 11 (11): 775–787. doi:10.1038/nri3086.
  • Salimi, M., S. Sarkar, S. Fathi, A. M. Alizadeh, R. Saber, F. Moradi, and H. Delavari. 2018. “Biodistribution, Pharmacokinetics, and Toxicity of Dendrimer-Coated Iron Oxide Nanoparticles in BALB/c Mice.” International Journal of Nanomedicine 13: 1483–1493. doi:10.2147/IJN.S157293.
  • Sangaiya, P., and R. A. Jayaprakash. 2018. “Review on Iron Oxide Nanoparticles and Their Biomedical Applications.” Journal of Superconductivity and Novel Magnetism 31 (11): 3397–3413. doi:10.1007/s10948-018-4841-2.
  • Saraiva, C., C. Praça, R. Ferreira, T. Santos, L. Ferreira, and L. Bernardino. 2016. “Nanoparticle-Mediated Brain Drug Delivery: Overcoming Blood–Brain Barrier to Treat Neurodegenerative Diseases.” Journal of Controlled Release : Official Journal of the Controlled Release Society 235: 34–47. doi:10.1016/j.jconrel.2016.05.044.
  • Schmid, D., V. Micić, S. Laumann, and T. Hofmann. 2015. “Measuring the Reactivity of Commercially Available Zero-Valent Iron Nanoparticles Used for Environmental Remediation with Iopromide.” Journal of Contaminant Hydrology 181: 36–45. doi:10.1016/j.jconhyd.2015.01.006.
  • Schneider, M., F. Stracke, S. Hansen, and U. F. Schaefer. 2009. “Nanoparticles and Their Interactions with the Dermal Barrier.” Dermato-endocrinology 1 (4): 197–206. doi:10.4161/derm.1.4.9501.
  • Sengul, A. B., and E. Asmatulu. 2020. “Toxicity of Metal and Metal Oxide Nanoparticles: A Review.” Environmental Chemistry Letters 18 (5): 1659–1683. doi:10.1007/s10311-020-01033-6.
  • Shabanova, E. M., A. S. Drozdov, A. F. Fakhardo, I. P. Dudanov, M. S. Kovalchuk, and V. V. Vinogradov. 2018. “Thrombin@Fe3O4 Nanoparticles for Use as a Hemostatic Agent in Internal Bleeding.” Scientific Reports 8 (1): 1–10. doi:10.1038/s41598-017-18665-4.
  • Shabanova, E. M., A. S. Drozdov, V. Ivanovski, I. I. Suvorova, and V. V. Vinogradov. 2016. “Collagenase@ Magnetite: Proteolytic Composite for Magnetically Targeted Minimally Invasive Surgery.” RSC Advances 6 (87): 84354–84362. doi:10.1039/C6RA14711A.
  • Shagholani, H., S. M. Ghoreishi, and S. H. Sharifi. 2018. “Conversion of Amine Groups on Chitosan-Coated SPIONs into Carbocyclic Acid and Investigation of Its Interaction with BSA in Drug Delivery Systems.” Journal of Drug Delivery Science and Technology 45: 373–377. doi:10.1016/j.jddst.2018.03.029.
  • Sharma, H. S., S. Hussain, J. Schlager, S. F. Ali, and A. Sharma. 2010. “Influence of Nanoparticles on Blood–brain Barrier Permeability and Brain Edema Formation in Rats.” Acta Neurochirurgica. Supplement 106: 359–364. doi:10.1007/978-3-211-98811-4_65.
  • She, X., B. Lan, H. Tian, and B. Tang. 2020. “Cross Talk between Ferroptosis and Cerebral Ischemia.” Frontiers in Neuroscience 14: 776. doi:10.3389/fnins.2020.00776.
  • Sheida, E., O. Sipailova, S. Miroshnikov, E. Sizova, S. Lebedev, E. Rusakova, and S. Notova. 2017. “The Effect of Iron Nanoparticles on Performance of Cognitive Tasks in Rats.” Environmental Science and Pollution Research International 24 (9): 8700–8710. doi:10.1007/s11356-017-8531-6.
  • Shelat, R., S. Ruchita, and A. Khanna. 2018. “Detailed Toxicity Evaluation of β-Cyclodextrin Coated Iron Oxide Nanoparticles for Biomedical Applications.” International Journal of Biological Macromolecules 110: 357–365. doi:10.1016/j.ijbiomac.2017.09.067.
  • Shen, Y., Z. Huang, X. Liu, J. Qian, J. Xu, X. Yang, A. Sun, et al. 2015. “Iron-Induced Myocardial Injury: An Alarming Side Effect of Superparamagnetic Iron Oxide Nanoparticles.” Journal of Cellular and Molecular Medicine 19 (8): 2032–2035. doi:10.1111/jcmm.12582.
  • Shi, Di, Gujie Mi, Soumya Bhattacharya, Suprabha Nayar, and Thomas J. Webster. 2016. “Optimizing Superparamagnetic Iron Oxide Nanoparticles as Drug Carriers Using an in Vitro Blood–Brain Barrier Model.” International Journal of Nanomedicine 11: 5371–5379. doi:10.2147/IJN.S108333.
  • Shi, M., L. Cheng, Z. Zhang, Z. Liu, and X. Mao. 2015. “Ferroferric Oxide Nanoparticles Induce Prosurvival Autophagy in Human Blood Cells by Modulating the Beclin 1/Bcl-2/VPS34 Complex.” International Journal of Nanomedicine 10: 207–216. doi:10.2147/ijn.s72598.
  • Shi, Y., Y. Li, and T. Coradin. 2020. “Magnetically-Oriented Type I collagen-SiO2@Fe3O4 Rods Composite Hydrogels Tuning Skin Cell Growth.” Colloids and Surfaces. B, Biointerfaces 185: 110597. doi:10.1016/j.colsurfb.2019.110597.
  • Shukla, S., A. Jadaun, V. Arora, R. K. Sinha, N. Biyani, and V. K. Jain. 2015. “In Vitro Toxicity Assessment of Chitosan Oligosaccharide Coated Iron Oxide Nanoparticles.” Toxicology Reports 2: 27–39. doi:10.1016/j.toxrep.2014.11.002.
  • Singh, N., G. J. Jenkins, R. Asadi, and S. H. Doak. 2010. “Potential Toxicity of Superparamagnetic Iron Oxide Nanoparticles (SPION).” Nano Reviews 1 (1): 5358. doi:10.3402/nano.v1i0.5358.
  • Singh, S. P., M. Kumari, S. I. Kumari, M. F. Rahman, M. Mahboob, and P. Grover. 2013. “Toxicity Assessment of Manganese Oxide Micro and Nanoparticles in Wistar Rats after 28 Days of Repeated Oral Exposure.” Journal of Applied Toxicology : JAT 33 (10): 1165–1179. doi:10.1002/jat.2887.
  • Srivastava, V., D. Gusain, and Y. C. Sharma. 2015. “Critical Review on the Toxicity of Some Widely Used Engineered Nanoparticles.” Industrial & Engineering Chemistry Research 54 (24): 6209–6233. doi:10.1021/acs.iecr.5b01610.
  • Sun, Z., M. Worden, Y. Wroczynskyj, V. Yathindranath, J. van Lierop, T. Hegmann, and D. W. Miller. 2014. “Magnetic Field Enhanced Convective Diffusion of Iron Oxide Nanoparticles in an Osmotically Disrupted Cell Culture Model of the Blood–Brain Barrier.” International Journal of Nanomedicine 9: 3013–3026. doi:10.2147/IJN.S62260.
  • Sundarraj, K., V. Manickam, A. Raghunath, M. Periyasamy, M. P. Viswanathan, and E. Perumal. 2017. “Repeated Exposure to Iron Oxide Nanoparticles Causes Testicular Toxicity in Mice.” Environmental Toxicology 32 (2): 594–608. doi:10.1002/tox.22262.
  • Szalay, B., E. Tátrai, G. Nyírő, T. Vezér, and G. Dura. 2012. “Potential Toxic Effects of Iron Oxide Nanoparticles in In Vivo and In Vitro Experiments.” Journal of Applied Toxicology : JAT 32 (6): 446–453. doi:10.1002/jat.1779.
  • Teleanu, D. M., C. Chircov, A. M. Grumezescu, and R. I. Teleanu. 2019. “Neurotoxicity of Nanomaterials: An Up-to-Date Overview.” Nanomaterials (Basel) 9 (1): 96. doi:10.3390/nano9010096.
  • Terrovitis, John, Matthias Stuber, Amr Youssef, Steve Preece, Michelle Leppo, Eddy Kizana, Michael Schär, et al. 2008. “Magnetic Resonance Imaging Overestimates Ferumoxide-Labeled Stem Cell Survival after Transplantation in the Heart.” Circulation 117 (12): 1555–1562. doi:10.1161/CIRCULATIONAHA.107.732073.
  • Tey, N. P., S. L. Lai, and J. K. Teh. 2016. “The Debilitating Effects of Chronic Diseases among the Oldest Old in China.” Maturitas 94: 39–45. doi:10.1016/j.maturitas.2016.08.016.
  • Thomsen, L. B., T. Linemann, K. M. Pondman, J. Lichota, K. S. Kim, R. J. Pieters, G. M. Visser, et al. 2013. “Uptake and Transport of Superparamagnetic Iron Oxide Nanoparticles through Human Brain Capillary Endothelial Cells.” ACS Chemical Neuroscience 4 (10): 1352–1360. doi:10.1021/cn400093z.
  • Toropova, Y. G., A. S. Golovkin, A. B. Malashicheva, D. V. Korolev, A. N. Gorshkov, K. G. Gareev, M. V. Afonin, et al. 2017. “In Vitro Toxicity of FemOn, FemOn-SiO2 Composite, and SiO2-FemOn Core-Shell Magnetic Nanoparticles.” International Journal of Nanomedicine 12: 593–603. doi:10.2147/IJN.S122580.
  • Tsoi, Kim M., Sonya A. MacParland, Xue-Zhong Ma, Vinzent N. Spetzler, Juan Echeverri, Ben Ouyang, Saleh M. Fadel, et al. 2016. “Mechanism of Hard-Nanomaterial Clearance by the Liver.” Nature Materials 15 (11): 1212–1221. doi:10.1038/nmat4718.
  • Tyner, K. M., N. Zheng, S. Choi, X. Xu, P. Zou, W. Jiang, C. Guo, et al. 2017. “How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities.” The AAPS Journal 19 (4): 1071–1083. doi:10.1208/s12248-017-0084-6.
  • Unterweger, H., C. Janko, M. Schwarz, L. Dézsi, R. Urbanics, J. Matuszak, E. Őrfi, et al. 2017. “Non-immunogenic Dextran-Coated Superparamagnetic Iron Oxide Nanoparticles: A Biocompatible, Size-Tunable Contrast Agent for Magnetic Resonance Imaging.” International Journal of Nanomedicine 12: 5223–5238. doi:10.2147/IJN.S138108.
  • Vakili-Ghartavol, R., A. A. Momtazi-Borojeni, Z. Vakili-Ghartavol, H. T. Aiyelabegan, M. R. Jaafari, S. M. Rezayat, and S. A. Bidgoli. 2020. “Toxicity Assessment of Superparamagnetic Iron Oxide Nanoparticles in Different Tissues.” Artificial Cells, Nanomedicine, and Biotechnology 48 (1): 443–451. doi:10.1080/21691401.2019.1709855.
  • Valdiglesias, Vanessa, Gözde Kiliç, Carla Costa, Natalia Fernández-Bertólez, Eduardo Pásaro, João Paulo Teixeira, Blanca Laffon, et al. 2015. “Effects of Iron Oxide Nanoparticles: Cytotoxicity, Genotoxicity, Developmental Toxicity, and Neurotoxicity.” Environmental and Molecular Mutagenesis 56 (2): 125–148. doi:10.1002/em.21909.
  • Valdiglesias, V., N. Fernández-Bertólez, G. Kiliç, C. Costa, S. Costa, S. Fraga, M. J. Bessaet, et al. 2016. “Are Iron Oxide Nanoparticles Safe? Current Knowledge and Future Perspectives.” Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS) 38: 53–63. doi:10.1016/j.jtemb.2016.03.017.
  • Van Rooy, I., S. Cakir-Tascioglu, W. E. Hennink, G. Storm, R. M. Schiffelers, and E. Mastrobattista. 2011. “In Vivo Methods to Study Uptake of Nanoparticles into the Brain.” Pharmaceutical Research 28 (3): 456–471. doi:10.1007/s11095-010-0291-7.
  • Varallyay, C. G., G. B. Toth, R. Fu, J. P. Netto, J. Firkins, P. Ambady, and E. A. Neuwelt. 2017. “What Does the Boxed Warning Tell us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent.” AJNR. American Journal of Neuroradiology 38 (7): 1297–1302. doi:10.3174/ajnr.A5188.
  • Voinov, M. A., J. O. Sosa Pagán, E. Morrison, T. I. Smirnova, and A. I. Smirnov. 2011. “Surface-Mediated Production of Hydroxyl Radicals as a Mechanism of Iron Oxide Nanoparticle Biotoxicity.” Journal of the American Chemical Society 133 (1): 35–41. doi:10.1021/ja104683w.
  • Wang, R., B. Song, J. Wu, Y. Zhang, A. Chen, and L. Shao. 2018. “Potential Adverse Effects of Nanoparticles on the Reproductive System.” International Journal of Nanomedicine 13: 8487–8506. doi:10.2147/IJN.S170723.
  • Wang, B., W. Feng, M. Zhu, Y. Wang, M. Wang, Y. Gu, H. Ouyang, et al. 2009. “Neurotoxicity of Low-Dose Repeatedly Intranasal Instillation of Nano-and Submicron-Sized Ferric Oxide Particles in Mice.” Journal of Nanoparticle Research 11 (1): 41–53. doi:10.1007/s11051-008-9452-6.
  • Wang, Jun, Yue Chen, Baoan Chen, Jiahua Ding, Guohua Xia, Chong Gao, Jian Cheng, et al. 2010. “Pharmacokinetic Parameters and Tissue Distribution of Magnetic Fe(3)O(4) Nanoparticles in Mice.” International Journal of Nanomedicine 5: 861–866. doi:10.2147/IJN.S13662.
  • Wang, Y., B. Wang, M. T. Zhu, M. Li, H. J. Wang, M. Wang, H. Ouyang, et al. 2011. “Microglial Activation, Recruitment and Phagocytosis as Linked Phenomena in Ferric Oxide Nanoparticle Exposure.” Toxicology Letters 205 (1): 26–37. doi:10.1016/j.toxlet.2011.05.001.
  • Wáng, Y. X. J., and J. M. Idée. 2017. “A Comprehensive Literatures Update of Clinical Researches of Superparamagnetic Resonance Iron Oxide Nanoparticles for Magnetic Resonance Imaging.” Quantitative Imaging in Medicine and Surgery 7 (1): 88–122. doi:10.21037/qims.2017.02.09.
  • Weissleder, R., D. D. Stark, B. L. Engelstad, B. R. Bacon, C. C. Compton, D. L. White, P. Jacobs, et al. 1989. “Superparamagnetic Iron Oxide: Pharmacokinetics and Toxicity.” AJR. American Journal of Roentgenology 152 (1): 167–173. doi:10.2214/ajr.152.1.167.
  • Wu, J., and J. Sun. 2011. “Investigation on Mechanism of Growth Arrest Induced by Iron Oxide Nanoparticles in PC12 Cells.” Journal of Nanoscience and Nanotechnology 11 (12): 11079–11083. doi:10.1166/jnn.2011.3948.
  • Wu, J., T. Ding, and J. Sun. 2013. “Neurotoxic Potential of Iron Oxide Nanoparticles in the Rat Brain Striatum and Hippocampus.” Neurotoxicology 34: 243–253. doi:10.1016/j.neuro.2012.09.006.
  • Wu, T., H. Xu, X. Liang, and M. Tang. 2019. “Caenorhabditis elegans as a Complete Model Organism for Biosafety Assessments of Nanoparticles.” Chemosphere 221: 708–726. doi:10.1016/j.chemosphere.2019.01.021.
  • Wu, X., Y. Tan, H. Mao, and M. Zhang. 2010. “Toxic Effects of Iron Oxide Nanoparticles on Human Umbilical Vein Endothelial Cells.” International Journal of Nanomedicine 5: 385–399.
  • Xue, Y., J. Wu, and J. Sun. 2012. “Four Types of Inorganic Nanoparticles Stimulate the Inflammatory Reaction in Brain Microglia and Damage Neurons in Vitro.” Toxicology Letters 214 (2): 91–98. doi:10.1016/j.toxlet.2012.08.009.
  • Yan, L., X. Liu, W. X. Liu, X. Q. Tan, F. Xiong, N. Gu, W. Hao, et al. 2015. “Fe2O3 Nanoparticles Suppress Kv1.3 Channels via Affecting the Redox Activity of Kvβ2 Subunit in Jurkat T Cells.” Nanotechnology 26 (50): 505103. doi:10.1088/0957-4484/26/50/505103.
  • Yang, H., C. Sun, Z. Fan, X. Tian, L. Yan, L. Du, Y. Liu, et al. 2012. “Effects of Gestational Age and Surface Modification on Materno-fetal Transfer of Nanoparticles in Murine Pregnancy.” Scientific Reports 2: 847. doi:10.1038/srep00847.
  • Yang, J. X., W. L. Tang, and X. X. Wang. 2010. “Superparamagnetic Iron Oxide Nanoparticles May Affect Endothelial Progenitor Cell Migration Ability and Adhesion Capacity.” Cytotherapy 12 (2): 251–259. doi:10.3109/14653240903446910.
  • Yang, L., H. Kuang, W. Zhang, Z. P. Aguilar, Y. Xiong, W. Lai, H. Xu, et al. 2015. “Size Dependent Biodistribution and Toxicokinetics of Iron Oxide Magnetic Nanoparticles in Mice.” Nanoscale 7 (2): 625–636. doi:10.1039/C4NR05061D.
  • Yang, Y. F., P. J. Chen, and V. H. Liao. 2016. “Nanoscale Zerovalent Iron (nZVI) at Environmentally Relevant Concentrations Induced Multigenerational Reproductive Toxicity in Caenorhabditis elegans.” Chemosphere 150: 615–623. doi:10.1016/j.chemosphere.2016.01.068.
  • Yarjanli, Z., K. Ghaedi, A. Esmaeili, S. Rahgozar, and A. Zarrabi. 2017. “Iron Oxide Nanoparticles May Damage to the Neural Tissue through Iron Accumulation, Oxidative Stress, and Protein Aggregation.” BMC Neuroscience 18 (1): 51. doi:10.1186/s12868-017-0369-9.
  • Ye, D., X. Zhang, Y. Yue, R. Raliya, P. Biswas, S. Taylor, Y. Tai, et al. 2018. “Focused Ultrasound Combined with Microbubble-Mediated Intranasal Delivery of Gold Nanoclusters to the Brain.” Journal of Controlled Release 286: 145–153. doi:10.1016/j.jconrel.2018.07.020.
  • Yildirimer, L., N. T. Thanh, M. Loizidou, and A. M. Seifalian. 2011. “Toxicology and Clinical Potential of Nanoparticles.” Nano Today 6 (6): 585–607. doi:10.1016/j.nantod.2011.10.001.
  • Yousef, M. I., A. A. Abuzreda, and M. K. Abdel-Nabi. 2019. “Cardiotoxicity and Lung Toxicity in Male Rats Induced by Long-Term Exposure to Iron Oxide and Silver Nanoparticles.” Experimental and Therapeutic Medicine 18 (6): 4329–4339. doi:10.3892/etm.2019.8108.
  • Yousefi, B. V., E. Amraeai, H. Salehh, L. Sadeghi, L. Najafi, and M. Fazilati. 2013. “Evaluation of Iron Oxide Nanoparticles Effects on Tissue and Enzymes of Thyroid in Rats.” International Research Journal of Biological Sciences 2: 67–69.
  • Yun, J. W., S. H. Kim, J. R. You, W. H. Kim, J. J. Jang, S. K. Min, H. C. Kim, et al. 2015. “Comparative Toxicity of Silicon Dioxide, Silver and Iron Oxide Nanoparticles after Repeated Oral Administration to Rats.” Journal of Applied Toxicology : JAT 35 (6): 681–693. doi:10.1002/jat.3125.
  • Zhang, Y. N., W. Poon, A. J. Tavares, I. D. McGilvray, and W. C. W. Chan. 2016. “Nanoparticle-Liver Interactions: Cellular Uptake and Hepatobiliary Elimination.” Journal of Controlled Release : Official Journal of the Controlled Release Society 240: 332–348. doi:10.1016/j.jconrel.2016.01.020.
  • Zhao, H., W. Gu, L. Ye, and H. Yang. 2014. “Biodistribution of PAMAM Dendrimer Conjugated Magnetic Nanoparticles in Mice.” Journal of Materials Science. Materials in Medicine 25 (3): 769–776. doi:10.1007/s10856-013-5104-1.
  • Zhao, S., X. Lin, L. Zhang, L. Sun, J. Li, W. Yang, and Z. Sun. 2012. “The in Vivo Investigation of Fe3O4-Nanoparticles Acute Toxicity in Mice Biomed.” Biomedical Engineering: Applications, Basis and Communications 24 (03): 229–235. doi:10.4015/S1016237212500056.
  • Zhu, L., Z. Zhou, H. Mao, and L. Yang. 2017. “Magnetic Nanoparticles for Precision Oncology: Theranostic Magnetic Iron Oxide Nanoparticles for Image-Guided and Targeted Cancer Therapy.” Nanomedicine (London, England) 12 (1): 73–87. doi:10.2217/nnm-2016-0316.
  • Zhu, M. T., B. Wang, Y. Wang, L. Yuan, H. J. Wang, M. Wang, H. Ouyang, et al. 2011. “Endothelial Dysfunction and Inflammation Induced by Iron Oxide Nanoparticle Exposure: Risk Factors for Early Atherosclerosis.” Toxicology Letters 203 (2): 162–171. doi:10.1016/j.toxlet.2011.03.021.
  • Zhu, M. T., Y. Wang, W. Y. Feng, B. Wang, M. Wang, H. Ouyang, and Z. F. Chai. 2010. “Oxidative Stress and Apoptosis Induced by Iron Oxide Nanoparticles in Cultured Human Umbilical Endothelial Cells.” Journal of Nanoscience and Nanotechnology 10 (12): 8584–8590. doi:10.1166/jnn.2010.2488.
  • Ziv-Polat, O., M. Topaz, T. Brosh, and S. Margel. 2010. “Enhancement of Incisional Wound Healing by Thrombin Conjugated Iron Oxide Nanoparticles.” Biomaterials 31 (4): 741–747. doi:10.1016/j.biomaterials.2009.09.093.
  • Zou, Jinglu, Xin Wang, Ling Zhang, and Jinke Wang. 2015. “Iron Nanoparticles Significantly Affect the in Vitro and in Vivo Expression of Id Genes.” Chemical Research in Toxicology 28 (3): 373–383. doi:10.1021/tx500333q.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.